Trial Profile

Asian Study on Cilostazol Effectivity in Neuropathies of Diabetes Mellitus Type 2-A Pilot Study in the Philippines (ASCEND).

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 10 Aug 2011

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Cilostazol (Primary)
Indications Diabetic neuropathies
Focus Therapeutic Use
Acronyms ASCEND
Sponsors Otsuka Pharmaceutical

Most Recent Events

06 Jul 2011 Secondary endpoint 'Walking-Impairment-Questionnaire' has been met.
06 Jul 2011 Primary endpoint 'Assessment-scale-scores' has not been met.
03 Mar 2010 New trial record

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com